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ABSTRACT
Background: Hypothermic circulatory arrest includes a 
remarkable risk for neurological injury. Diazoxide, a mito-
chondrial adenosine triphosphate–dependent potassium ion 
(K+ATP) channel opener, is known to have cardioprotective 
effects. We assessed its efficacy in preventing ischemic injury 
in a clinically relevant animal model. 
Methods: Eighteen piglets were randomized into a 
diazoxide group (n = 9) and a control group (n = 9). Animals 
underwent 60 minutes of hypothermic circulatory arrest at 
18°C. Diazoxide (5 mg/kg + 10 mL NaOH + 40 mL NaCl) 
was infused during the cooling phase. Metabolic and hemody-
namic data were collected throughout the experiment. After 
24-hour follow-up, whole brain, heart, and kidney biopsy 
specimens were collected for analysis. 
Results: Cerebellar Cytochrome-C and caspase-3 
activation was higher in the control group (P = .02 and 
P = .016, respectively). Antioxidant activity tended to be 
higher in the diazoxide group (P = .099). Throughout the 
experiment, the oxygen consumption ratio was higher in 
the control animals (Pg = .04), as were the lactate levels 
(Pg = .02). Cardiac function tended to be better in diazox-
ide-treated animals. 
Conclusion: Diazoxide might confer neuroprotective 
effect as implied by the immunohistochemical analysis of the 
brain. Additionally, the circulatory effects of diazoxide were 
beneficial, supporting its neuroprotective effect. 
INTRODUCTION
Cardiopulmonary bypass (CPB) with intervals of hypother-
mic circulatory arrest (HCA) enables a bloodless operating 
field, but there is, however, an increased risk for neurological 
impairment when the circulation is halted. The severity of the 
neurological injury correlates in particular with emergency 
situations and longer circulatory arrest times [Svensson 1993; 
Gega 2007]. Thus, there is a need for a neuroprotective tool 
in the field of complex cardiac and aortic surgery.
Diazoxide was found to react with adenosine triphosphate 
(ATP)-dependent potassium ion (K+ATP) channels [Trube 
1986; Standen 1989], which consequently resulted in the 
finding that diazoxide has a powerful cardioprotective effect 
[Garlid 1997; Nakai 1994]. Most interestingly, the evidence 
from experimental studies is also advocating the neuropro-
tective effect of diazoxide [Roseborough 2006; Wang 2011].
A similar K+ATP channel was purified from the inner mito-
chondrial membrane (mK+ATP channel) [Paucek 1992], leading 
to the subsequent finding that diazoxide directly increases K+ 
fluxes in isolated mitochondria [Liu 2001]. This might pre-
vent the self-destruction signaling pathway of the cell [Korge 
2002]. The target of diazoxide is of the most interest in the 
context of neuroprotection, as the brain mitochondria appar-
ently contain seven times more mK+ATP channels compared 
to liver and heart cells [Bajgar 2001]. 
The abundant production of reactive oxygen species (ROS) 
due to ischemia reacts with DNA, leaving a specific footprint: 
8-hydroxydeoxyguanosine (8-OHdG), which can be reliably 
measured with a specific antibody. 8-Oxoguanine glycosylase 
(OGG1) removes 8-OHdG from the damaged DNA that is 
then secreted into the bloodstream [Valavanidis 2009; Abedin 
2013]. Nuclear erythroid-related factor-2 (Nrf-2) is, in turn, 
a sensor for cellular redox status and is activated and translo-
cated to the nucleus when exposed to oxidative stress. In the 
nucleus, it binds to the antioxidant response element, caus-
ing the transcription of multiple cytoprotective proteins and 
is thus related to cell protection during ischemia [Mitsuishi 
2012]. Additionally, deglycase (DJ-1)/Parkinson disease pro-
tein 7 is a multifunctional redox-regulating protein associated 
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with the mitigation of oxidative stress injury [Mitsumoto 
2001]. Lastly, ischemic injury to the mitochondria is observed 
in the form of excessive cytochrome C release, which acti-
vates the cell death cascades, including caspase-3 activation 
[Zhan 2001].
In this study, we postulated that diazoxide might protect 
against ischemic insult and have beneficial circulatory effects. 
The primary end point was the immunohistochemical analysis 
of the brain while the secondary objective was to analyze the 
global effect of diazoxide and its relation to cerebral injury. 
The hypothesis was tested in a porcine model with 60-minute 
HCA at 18°C as the model allowed us to mimic clinical pro-
cedures and explore both intraoperative parameters and brain 
histology after ischemia.
MATERIALS AND METHODS
Experimental Setting
Eighteen female juvenile pigs from a native stock (range, 
19.4-22.6 kg) were randomized into two groups using sealed 
envelopes: an intervention group (n = 9) and a control group 
(n = 9). An intravenous infusion of diazoxide (5 mg/kg + 10 mL 
NaOH + 40 mL NaCl) was administered to the intervention 
group before the 60 minutes of HCA. The control group was 
treated in the same manner as the intervention group, and the 
infused solution was identical but for the absence of diazoxide. 
Preoperative Management
All animals received humane care by the Principles of Lab-
oratory Animal Care formulated by the National Society for 
Medical Research and with the Guide for the Care and Use 
of Laboratory Animals (http://www.nap.edu/catalog/5140.
html). The study was approved by the Research Animal Care 
and Use Committee of the University of Oulu.
Anesthesia Protocol and Surgical Management 
Anesthesia induction and donor blood collection were 
carried out similarly as in our previous study [Jensen 2011]. 
Animals underwent 60 minutes of HCA at 18°C. Left groin 
procedures for hemodynamic monitoring and CPB using 
pH-stat strategy were performed as previously described in 
our study [Jensen 2011]. 
Diazoxide Infusion
Diazoxide (D9035 Sigma, Sigma-Aldrich, St. Louis, 
MO, USA) was first dissolved in 8–10 mL sodium hydrox-
ide (1 mol/L) and this solution was further diluted with 40 
mL sodium chloride. The diazoxide infusion (5 mg/kg) was 
started at the beginning of the cooling phase, and it ended 10 
minutes before HCA. The injection was performed through 
the pulmonary artery catheter to ensure a systemic effect. 
Figure 1. Oxygen consumption ratio. The oxygen consumption was sig-
nificantly higher after the hypothermic circulatory arrest, whereas the 
diazoxide group did not reach the baseline level until 4 hours postop-
eratively. PoP indicates postoperatively.
Figure 2. Cardiac output and significant arrhythmias. The left figure is 
showing that the hemodynamically unstable arrhythmias occurred more 
often in the control group. Arrhythmia was considered as unstable when 
the drop in mean arterial pressure was over 20% from baseline value. 
The heart function recovered faster in the diazoxide group as seen in 
cardiac index. The values are referred to baseline value and presented 
as percentage change. PoP indicates postoperatively.
Figure 3. Venous lactate. The venous lactate levels were significantly 
higher in the control group after the weaning from cardiopulmonary 
bypass. Additionally, the decrease of lactate level was more rapid in the 
diazoxide group. PoP indicates postoperatively.
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The pulmonary artery catheter was rinsed with an additional 
10 mL saline after the end of the infusion. The control group 
was infused with 40 mL saline and 10 mL NaOH during the 
cooling phase of the CPB. 
Cranial Procedures
A cranial window was created on the right side of the skull 
from the coronal suture with a 14 mm/11 mm disposable 
cranial perforator (200-253 DGR-II, Acra Cut, Acton, MA, 
USA) after 8 hours from the end of HCA. The left hemisphere 
was biopsied and immediately immersed in 10% formalin for 
histopathological analysis. Hemostasis was achieved, and the 
skin flap was sutured.
Biochemical Data
Blood gas values and pH, electrolyte, plasma lac-
tate, serum ionized calcium, glucose, hematocrit, and 
hemoglobin levels were measured, and plasma samples 
were collected at baseline, at 20 minutes after the start of 
the cooling, 1 hour, 2 hours, 4 hours, and 8 hours after 
the end of HCA (i-STAT Analyzer; i-STAT Corporation, 
East Windsor, NJ, USA). Additionally, central temperature 
readings, urine amount, and the amount of fluids infused 
were recorded.
Postoperative Management
Mean arterial pressure was maintained at over 60 mmHg 
with noradrenalin if necessary. The animals were held 
under general anesthesia until 24 hours from the start of 
HCA. At that point, each animal was electively euthanised 
with an injection of pentobarbital (60 mg/kg). Immediately 
after that, whole brain, heart, and right kidney samples 
were harvested and immersed in 10% neutral formalin for 
two weeks. 
Table 1. Metabolic Data
After the start of rewarming
Variable Baseline Cooling 20 1h post op 2h postop 4h postop 8h postop Pg Pt*g
pH .84 .06
Diazoxide 7.53 (7.50-7.54) 7.56 (7.51-7.58) 7.43 (7.40-7.44) 7.51 (7.48-7.51) 7.53 (7.48-7.53) 7.48 (7.47-7.50)
Control 7.51 (7.50-7.42) 7.61 (7.57-7.64) 7.44 (7.39-7.43) 7.48 (7.47-7.49) 7.50 (7.49-7.52) 7.51 (7.48-7.52)
PaCO2, kPa .23 .047
Diazoxide 4.99 (4.92-5.41) 3.64 (3.50-4.21) 5.19 (4.81-5.40) 5.58 (4.98-5.62) 5.46 (5.28-5.91) 5.59 (5.20-5.62)
Control 5.09 (4.90-5.45) 3.29 (2.95-3.73) 5.15 (4.93-5.26) 5.02 (4.98-5.40) 5.25 (5.18-5.35) 5.51 (5.03-5.75)
PaO2, kPa .63 .70
Diazoxide 39.2 (36.7-40.9) 106 (106-106) 22.2 (20.3-29.7)* 33.4 (20.7-37.2) 34.0 (27.7-36.5) 35.2 (30.9-37.9)
Control 38.5 (37.0-41.6) 106 (106-106) 20.2 (16.1-34.4) 28.6 (22.0-37.8) 25.6 (19.9-35.7) 35.8 (26.2-37.1)
Hematocrit, % .84 .001
Diazoxide 23.0 (23.0-25.0)* 25.0 (24.0-26.0) 31.0 (30.0-34.0) 31.0 (30.0-35.0) 27.0 (26.0-29.0) 24.0 (22.0-26.0)
Control 25.0 (24.0-27.0) 25.0 (23.0-27.0) 30.0 (29.0-31.0) 33.0 (30.0-34.0) 27.0 (26.0-31.0) 26.0 (24.0-30.0)
Hemoglobin, g/L .88 .001
Diazoxide 78 (78-85)* 88 (82-88) 105 (102-116) 105 (102-109) 92 (88-99) 82 (75-88)
Control 85 (82-92) 85 (78-92) 102 (99-105) 112 (102-116) 92 (88-105) 88 (81-102)
P-Gluc, mmol/L .27 .77
Diazoxide 5.1 (4.8-5.6) 3.1 (2.8-4.0) 2.5 (1.3-4.4) 5.3 (4.6-6.8) 6.8 (5.7-7.1) 5.8 (4.9-7.0)*
Control 5.7 (4.7-6.3) 4.1 (3.6-5.1) 4.8 (2.4-6.6) 6.1 (4.1-6.4) 6.8 (5.6-7.1) 4.7 (4.0-5.7)
CK-MB, lU/L .35 .63
Diazoxide 4.7 (3.1-7.6) 16.9 (12.7-21.1) 42.3 (34.3-60.6) 55.9 (44.7-73.1) 55.6 (44.0-70.3) 40.7 (34.1-58.9)
Control 5.2 (4.2-6.8) 16.7 (13.0-23.6) 53.3 (42.7-70.7) 60.6 (45.0-77.2) 62.0 (40.0-80.7) 53.9 (40.1-78.6)
Troponin I, μg/L .83 .84
Diazoxide 0.14 (0.076-0.22) 3.3 (2.7-4.8) 16.2 (12.4-27.7) 26.4 (18.0-36.9) 43.3 (24.8-56.4) 38.6 (21.0-45.3)
Control 0.18 (0.085-0.24) 4.1 (3.4-4.5) 20.7 (13.3-38.0) 27.5 (16.5-43.7) 49.0 (29.7-7.8) 35.3 (26.6-52.2)
Diazoxide, n = 9; control, n = 9. Values are shown as medians and 25th and 75th percentiles. *P < .05 at the single time point. P-gluc, venous glucose.
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Histopathological Analysis
Hematoxylin–eosin staining was conducted as described 
in our previous study [Jensen 2011]. Immunohistochemical 
staining was used for more detailed analysis of oxidative stress 
and cell death. Six factors related to oxidative stress were 
determined: Nrf-2, OGG1, 8-OHdG, DJ-1, cytochrome C, 
and activated (cleaved) caspase-3.
Sections (4.5 μm) cut from paraffin-embedded specimens 
were deparaffinized in xylene and rehydrated through graded 
alcohols. For antigen retrieval, the sections were pretreated 
with either Tris–EDTA (pH 9) or with citrate buffer (pH 
6) in a microwave oven. After neutralizing the endogenous 
peroxidase activity, the sections were incubated at room 
temperature with diluted antibodies. Bound antibodies were 
Table 2. Hemodynamic Data
After the start of rewarming
Variable Baseline Cooling 20 1h postop 2h postop 4h postop 8h post op P
g
P
t*g
MAP, mmHg .65 .074
Diazoxide 91 (87-107) 61 (60-62) 78 (75-80) 79 (74-90) 72 (64-76) 64 (60-68)
Control 83 (75-91) 61 (60-62) 84 (79-88) 79 (78-82) 74 (68-80) 66 (65-73)
CVP, mmHg .30 .97
Diazoxide 3 (1-3) 4 (3-4) 4 (3-4) 4 (2 -6) 5 (4-5) 5 (4-6)*
Control 3 (2-5) 3 (2-5) 5 (2-6) 6 (4-7) 5 (5-6) 7 (6-8)
Heart rate, bpm .70 .47
Diazoxide 136 (127-145) — 129 (122-137) 125 (117-133) 132 (128-136) 131 (130-142)
Control 126 (112-145) — 132 (115-153) 110 (100-126) 126 (118-128) 122 (114-132)
T (rectal), °C .40 .0058
Diazoxide 38.8 (38.3-
39.5)
20.8 (17.7-
24.0)
35.6 (35.5-
36.0)
36.2 (36.1-
36.4)
38.0 (37.4-
38.1)
37.4 (36.9-
37.6)
Control 39.0 (38.1-
39.6)
23.9 (21.9-
28.0)
34.4 (33.6-
35.8)
36.0 (34.8-
36.7)
37.5 (37.1-
38.4)
37.1 (36.4-
37.9)
T (blood), °C .58 .32
Diazoxide 38.9 (38.7-
39.7)
15.8 (15.4-
16.1)
35.6 (35.2-
35.7)
36.5 (36.1-
36.9)
38.1 (37.9-
38.5)
37.8 (37.7-
38.2)
Control 39.0 (38.5-
39.5)
15.6 (15.3-
16.7)
35.3 (34.5-
35.9)
35.7 (35.1-
36.5)
37.5 (37.3-
37.9)
36.8 (36.2-
37.8)
CI, mL x min-1 x m-2 .13 .087
Diazoxide 3.78 (3.38-
4.23)
2.75 (2.53-
3.19)
3.78 (3.28-
4.42)
4.05 (3.27-
4.25)
3.63 (3.21-
4.21)
3.98 (3.40-
5.08)*
Control 4.27 (3.97-
4.75)
2.83 (2.38-
3.03)
3.52 (2.49-
3.61)
3.31 (2.49-
3.61)
3.46 (3.27-
3.56)
2.94 (2.68-
3.68)
O2consumption, mL × min-1 × m-2 .88 .057
Diazoxide 15.3 (11.9-
17.1)
7.4 (7.2-8.6) 16.3 (11.6-
17.1)
16.3 (15.3-
16.7)
17.0 (16.1-
18.5)
16.3 (14.4-
17.7)
Control 16.1 (15.8-
18.2)
7.8 (6.2-8.9) 15.8 (14.1-
17.4)
16.0 (14.0-
16.6)
15.8 (15.5-
16.4)
15.1 (11.9-
17.3)
O2 delivery, mL × min-1 × m-2 .074 .028
Diazoxide 49.8 (39.4-
54.4)
38.1 (31.1-
46.6)
56.2 (53.6-
65.7)*
61.1 (52.2-
62.4)*
58.8 (42.8-
60.2)
51.2 (41.5-
57.6)
Control 57.0 (55.9-
58.8)
39.1 (34.8-
43.0)
42.2 (37.1-
59.0)
52.2. (38.4-
59.3)
44.7 (42.3-
50.5)
40.2 (35.1-
45.6)
Diazoxide, n = 9; control, n = 9. Values are shown as medians and 25th and 75th percentiles. *P < .05 at the single time point. CI indicates cardiac index; CVP, 
central venous pressure; MAP, mean arterial pressure; T, temperature.
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detected using the EnVision, EnVision FLEX (Dako, Agilent 
Technologies, Santa Clara, CA, USA), or Invitrogen systems 
(Thermo Fischer Scientific, Waltham, MA, USA). Diamino-
benzidine was used as the chromogen and hematoxylin as the 
counterstain.
Five predetermined areas in the brains were sampled: cere-
bral cortex, thalamic region, cerebellum, pons, and medulla. 
These samples were then stained with hematoxylin–eosin 
and immunohistochemical stains and scored by a neuropa-
thologist blinded to the grouping. Hematoxylin–eosin scor-
ing was based on the presence of edema (0–3), hemorrhage 
(0, 2–3), neuron degeneration (0, 2–3), and the presence of 
infarcted tissue (0, 3). Immunohistochemical analysis was 
based on four grades as follows: 0 = negative, 1 = mild, 2 = 
moderate, 3 = strong staining intensity. Additionally, brain 
biopsy, as well as kidney and heart samples, were analyzed 
immunohistochemically. 
Statistical Analysis
Statistical analysis was performed using the SPSS (ver-
sion 22.0; SPSS, Chicago, IL, USA) and SAS (version 9.2; 
SAS Institute, Cary, NC, USA) statistical software packages. 
Continuous and ordinal variables are expressed as the median 
and 25th and 75th percentiles in the tables and figures. The 
repeatedly measured data were analyzed using a linear mixed 
model with animals fitted as random effects, and the best cova-
riance pattern was chosen according to Akaike’s information 
criteria. Complete independence was assumed across animals 
(by random statement). Reported P values are as follows: P 
between groups (Pg) indicates a level of difference between 
the groups, P time · group (Pt · g) means behavior between the 
groups over time. Student t test or the Mann-Whitney U test 
was used as appropriate to assess the distribution of variables 
between the study groups. Two-tailed significance levels are 
reported. P < .05 was considered statistically significant. 
RESULTS
Comparability of the Study Groups
The median weight of the animals was 20.3 kg in the 
diazoxide group and 20.7 kg in the control group (P = .412). 
The diazoxide group received 76.4 mL/kg (range, 73.2–79.8 
mL/kg) donor blood and the control group was given 74.5 
mL/kg (range, 69.1–78.4 mL/kg), respectively (P = .242). 
The cumulative amount of inotropes at the end of the experi-
ment did not differ between groups (Pg = .750). Blood and 
rectal temperatures were similar throughout the experiment 
(Pg = .580 and Pg = .400, respectively); additionally, the rectal 
temperature was similar during HCA (Pt · g = 0.18). Hemo-
globin and hematocrit were significantly different at baseline, 
but the difference leveled out until the beginning of HCA 
(Table 1). Mortality was higher in the control group, as two 
animals died during the overnight surveillance (22.2% versus 
0%). The metabolic and experimental data are summarized 
in Tables 1 and 2. 
Oxygen Metabolism
The oxygen extraction ratio (ratio of consumption and 
delivery) indicated that oxygen consumption was significantly 
higher in the control group after HCA (Figure 1). The most 
apparent difference was 1 hour after the start of rewarming, 
where a steep increase in consumption was observed. The 
consumption increased consistently after that in the control 
group, whereas in the diazoxide group, the baseline level was 
not reached until 4 hours after HCA.
Cardiac Output and Arrhythmias
After weaning from the CPB, the cardiac index in the 
diazoxide group appeared to exceed the baseline level after 
HCA, while it was considerably lower in the control group 
(Figure 2) although statistical significance was not reached 
(Pt · g = .087), as presented in Table 2. Hemodynamically unsta-
ble arrhythmias (transient ventricular tachycardia or fibril-
lation and atrial fibrillation with fast ventricular response) 
were recorded in 7 of 9 animals in the control group, whereas 
they were recorded in 3 of 9 animals in the diazoxide group 
(P = .063). An arrhythmia was considered hemodynamically 
unstable if the decrease of MAP was over 20% of the baseline 
value (Figure 2). 
Venous Lactate
In the diazoxide group, venous lactate levels after HCA 
were decreased faster compared to the control group. More-
over, the increase in the lactate concentration during and 
after CPB was not as high in the diazoxide group as in the 
control group (Figure 3). 
Histopathological Analysis
The cytoplasmic expression of Nrf-2 tended to be more 
expressed in the brains of the diazoxide-treated animals (Sum 
score, P = .099). Cytochrome C and activated caspase-3 levels 
Figure 4. Immunohistochemical staining of the cerebellum revealing the 
activity of cytochrome C. The analysis was based on four grades as fol-
lows: 0 = negative, 1 = mild (A), 2 = moderate (B), 3 = strong (C) stain-
ing intensity. The grading was measured from the Purkinje cells activity 
(arrowheads).
Figure 5. Immunohistochemical staining of the cerebellum revealing the 
activity of activated caspase 3. The analysis was based on four grades 
as follows: 0 = negative, 1 = mild (A), 2 = moderate (B), 3 = strong 
(C) staining intensity. The grading was measured from the Purkinje cells 
activity (arrowheads).
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were higher in the cerebellum in the control group (P = .02 
and P = .016, respectively). The examples of cytochrome C 
and activated caspase-3 grading are demonstrated in Figures 
4 and 5. Levels of the oxidative stress marker 8-OHdG did 
not differ significantly between groups, and its expression was 
rather mild in both groups (P = .939). The summarized immu-
nohistochemical analysis is presented in Table 3. The analysis 
of the heart, kidney, and cerebral biopsy were minimal and 
not statistically significantly different. The main findings in 
the hematoxylin-eosin analysis were oedema (P = .261) and 
hemorrhage (P = .483). 
DISCUSSION
Hypothermia reduces the metabolic rate of cerebral tissue 
by approximately 50% per 6°C drop in tissue temperature 
[Kouchoukos 2013]. There has been, however, constant con-
cern about the increased risk of neurologic deficit related to 
HCA [Gega 2007]. This has led to the innovation of various 
adjuncts to enhance the safety of HCA. In the present study, 
we used a clinically relevant animal model of HCA to investi-
gate effects of diazoxide. Interestingly, it appeared diazoxide 
tended to enhance the antioxidant response in the brain after 
ischemic insult, preserved cellular metabolic capability, as 
well as improved cardiac function. 
Initially, the Food and Drug Administration of the United 
States approved diazoxide for the treatment of symptomatic 
hypoglycemia in 1976. The intravenous form of diazoxide is 
also used for malignant hypertension due to its vasodilatory 
effect. Due to the hypotensive effect, we introduced diazoxide 
after the porcine was cannulated for CPB, which enabled us 
to control the hemodynamics.
Several hypotheses have been proposed to explain the con-
tribution of mK+ATP channels in cellular protection. According 
to the isolated mitochondria studies, the leading theory of the 
beneficial effect of diazoxide is that the mK+ATP channel open-
ing promotes mild mitochondrial swelling, which may pre-
serve the structure and function of the intermembrane space 
Table 3. Results of Immunohistochemical Analysis of the Brain
Frontal cortex Hippocampus Pons Cerebellum Thalamus Sum score
8-OHdG
Diazoxide 1.0 (0.0-1.0) 0.0 (0.0-2.0) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-0.0) 3.0 (2.0-4.0)
Control 1.0 (0.0-1.0) 0.0 (0.0-1.0) 1.0 (0.5-2.0) 0.0 (0.0-0.5) 0.0 (0.0-1.0) 4.0 (1.0-5.0)
P .900 .243 .619 .414 .243 .939
OGG1
Diazoxide 1.0 (1.0-2.0) 1.0 (1.0-2.0) 2.0 (2.0-3.0) 2.0 (2.0-3.0) 1.0 (1.0-1.0) 9.0 (7.0-10.0)
Control 2.0 (1.0-2.0) 2.0 (1.0-2.0) 3.0 (2.0-3.0) 2.0 (2.0-2.5) 2.0 (1.0-2.0) 10.0 (9.5-10.0)
P .278 .769 .623 .934 .472 .417
NFR-2
Diazoxide 1.0 (0.0-2.0) 1.0 (0.0-2.0) 1.0 (0.0-1.0) 1.0 (1.0-3.0) 2.0 (1.0-2.0) 5.0 (3.0-13.0)
Control 0.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) 1.0 (0.5-1.0) 0.0 (0.0-1.0) 2.0 (2.0-4.5)
P .342 .237 .312 .089 .06 .099
Cleaved Caspase-3
Diazoxide 3.0 (3.0-3.0) 2.0 (2.0-2.0) 2.0 (2.0-3.0) 1.0 (1.0-1.0) 2.0 (2.0-3.0) 10.5 (10.0-11.0)
Control 3.0 (2.0-3.0) 2.0 (1.0-2.0) 2.0 (2.0-2.0) 2.0 (1.5-2.5) 3.0 (2.0-3.0) 11.0 (10.0-11.0)
P .411 .449 .375 .016 .435 .710
Cyt C
Diazoxide 2.0 (1.0-2.0) 2.0 (2.0-2.0) 3.0 (2.0-3.0) 1.0 (1.0-2.0) 2.0 (2.0-2.0) 10.0 (7.0-11.0)
Control 2.0 (1.5-2.0) 2.0 (2.0-2.0) 2.0 (2.0-3.0) 2.0 (2.0-3.0) 2.0 (2.0-2.0) 10.0 (8.5-11.5)
P .861 1.0 .898 .021 .531 .442
DJ-1/PARK7
Diazoxide 1.0 (0.0-1.0) 0.0 (0.0-0.5) 1.5 (0.5-2.0) 0.0 (0.0-0.5) 1.0 (0.0-1.0) 3.5 (1.0-6.5)
Control 1.0 (1.0-1.0) 0.0 (0.0-1.0) 1.0 (0.0-1.0) 0.0 (0.0-0.5) 0.5 (0.0-1.0) 3.0 (2.0-5.0)
P .942 .732 .373 .887 .250 .579
Diazoxide, n = 9; control, n = 7. The results are presented as median values 25th and 75th percentiles in parenthesis. Cyt C indicates cytochrome C. 
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[Kowaltowski 2001]. Ischemia causes mitochondrial depolar-
ization, which results in disturbance of the intermembrane 
space and accelerates ATP hydrolysis due to the disruption of 
mitochondrial creatine kinase [Kay 1997]. Thus, the mecha-
nism of diazoxide via mK+ATP channels might slow ATP hydro-
lysis and keep creatine kinase functional until reperfusion by 
preserving the intermembrane architecture. Additionally, the 
increase in ROS production has been associated with the use 
of diazoxide and mK+ATP channel opening. The precise mech-
anism is unknown, but it has been proposed that ROS might 
function as a second messenger during diazoxide precondi-
tioning as well as in ischemic preconditioning [Pain 2000]. 
Immunohistochemical analysis of the brain revealed the 
most impressive results. The statistical significance was not 
reached, but the tendency of more activated antioxidant path-
ways in the diazoxide-treated animals was apparent, although 
other oxidative stress markers did not show higher activity. 
Nrf-2 is stabilized when exposed to ROS or specific drugs, 
and it is translocated to the nucleus, where the transcrip-
tion of various cytoprotective genes is initiated [Mitsuishi 
2012]. This finding may support the theory of ROS being the 
second messenger, although we cannot directly conclude that 
because the Nrf-2 activity was found only in the cytoplasm. 
Interestingly, similar results have been reported from IPC 
studies as well [Bell 2011]. This might also explain the lack 
of difference in 8-OHdG, which is thought to be the most 
sensitive marker for DNA injury caused by ROS [Valavani-
dis 2009]. Moreover, cytochrome C release and subsequently 
cleaved caspase-3 activation were higher in the cerebellum in 
the control group. Obviously, this indicates diazoxide might 
have the ability to preserve mitochondrial viability, but the 
difference was significant only in one brain area.
As a means to demonstrate the systemic effect of diazox-
ide, we documented improved oxygen consumption ratio and 
lower lactate levels in the diazoxide group might indicate 
better cellular function after ischemic insult. These findings 
are congruent with the suggested effect of mK+ATP channel 
opening at the systemic level, as the reversible uncoupling of 
ATP hydrolysis will preserve energy stores upon reperfusion. 
Although these findings cannot be applied straightforwardly 
to the cerebral tissue protection, the beneficial systemic 
effects might lower the risk of cerebral injury. 
The functional parameters of the heart were favorable in 
the diazoxide group. The better cardiac function might have 
a role in the neuroprotective findings of the diazoxide-treated 
animals, as the cerebral blood flow would be stabilized due to 
more efficient systemic circulation. In the first instance, isch-
emia-sensitive cerebral areas are compromised due to labile 
circulation, and thus the focal findings in cerebral immuno-
histochemistry may be partially explained by the circulatory 
effects of diazoxide.
The study carries several limitations. The model was acute, 
and therefore we do not have long-term surveillance and 
neurological, behavioral analysis. Additionally, the amount of 
infused diazoxide varies widely between studies from 1 mg/
kg to 10 mg/kg [Coetzee 2013]. There are no data on the 
optimal therapeutic window of diazoxide, and thus various 
doses might be more effective than the dose (5 mg/kg) we 
used.  Although we cannot draw absolute conclusions about 
the beneficial effects of diazoxide, there are multiple param-
eters indicating its advantages. In addition to the biochemical 
and histological findings, there were two deaths in the con-
trol group, which were most probably related to heart failure, 
supporting the benefits of diazoxide.
In conclusion, the present study showed the beneficial 
effects of diazoxide against global ischemia as well as evidence 
of mitigated cerebral injury. Additionally, we were able to 
observe indirect indications of preserved mitochondrial func-
tion in a clinically relevant animal model. 
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